StoxGud Sign in
50

Anuh Pharma Limited

NSE: ANUHPHR · Unclassified

₹81.55-0.74%06 Nov 2026

Ask the data

Instant answers about Anuh Pharma Limited — computed from its filings, no language model
Market cap₹817 cr
Current price₹81.55
High / Low₹97 / ₹67
P/E17.1
P/B2.27
Book value₹35.9
ROE13.3%
ROCE17.3%
Debt / equity0.05
Dividend yield1.83%
EPS (TTM)₹4.77
Face value₹5

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin
showing latest 6 of 18 periods
FY09†FY10†FY11†FY12†FY13†FY14†FY15†FY16†FY17†FY18†FY19†FY20†FY21†FY22†FY23†FY24†FY25FY26
Revenue120.6164.6175.6224.6242.7266.4283.7326.9206.2240.6320.7307.0432.0486.6527.5647.0661.5771.7
EBITDA19.810.715.219.419.326.832.939.323.219.229.522.844.647.251.375.260.961.7
Operating margin16.4%6.5%8.7%8.7%7.9%10.0%11.6%12.0%11.2%8.0%9.2%7.4%10.3%9.7%9.7%11.6%9.2%8.0%
Interest0.80.10.10.40.00.10.10.00.00.00.20.81.51.30.20.30.60.5
Depreciation1.11.21.11.31.71.83.32.32.01.81.77.015.112.09.78.68.711.4
Profit before tax14.217.917.418.017.725.531.937.925.125.632.419.238.539.147.578.361.054.2
Tax4.45.15.25.25.27.99.912.17.56.99.04.810.18.611.318.213.713.2
Net profit9.812.812.112.812.517.622.025.817.618.723.414.328.430.636.260.047.441.0
EPS ₹————————————————9.454.10
Operating cash flow————————————————37.1-3.0
Capex————————————————20.07.9
Dividend paid————————————————12.515.0
Total assets————————————————506.6557.4
Equity————————————————326.0352.2

Quarterly performance

last 77 quarters · ₹ crore
showing latest 8 of 77 periods
SEP '07†DEC '07†MAR '08†JUN '08†SEP '08†DEC '08†MAR '09†JUN '09†SEP '09†DEC '09†MAR '10†JUN '10†SEP '10†DEC '10†MAR '11†JUN '11†SEP '11†DEC '11†MAR '12†JUN '12†SEP '12†DEC '12†MAR '13†JUN '13†SEP '13†DEC '13†MAR '14†JUN '14†SEP '14†DEC '14†MAR '15†JUN '15†SEP '15†DEC '15†MAR '16†JUN '16†SEP '16†DEC '16†MAR '17†JUN '17†SEP '17†DEC '17†MAR '18†JUN '18†SEP '18†DEC '18†MAR '19†JUN '19†SEP '19†DEC '19†MAR '20†JUN '20†SEP '20†DEC '20†MAR '21†JUN '21†SEP '21†DEC '21†MAR '22†JUN '22†SEP '22†DEC '22†MAR '23†JUN '23†SEP '23†DEC '23†MAR '24†JUN '24†SEP '24†DEC '24MAR '25JUN '25SEP '25DEC '25MAR '26JUN '26SEP '26
Revenue28.126.832.432.535.526.126.637.836.145.944.838.051.246.240.150.859.665.748.465.852.465.658.955.667.466.876.675.371.166.370.986.891.578.570.149.150.252.154.754.855.363.367.180.287.470.083.084.974.275.972.0124.2112.298.397.2117.3108.7131.7129.0116.4115.1138.7157.3161.5149.5172.1163.9137.9165.9159.5198.1186.5185.9197.2202.1193.8185.2
Operating profit3.02.93.05.96.94.52.53.73.32.21.53.84.83.33.34.15.08.02.47.84.13.83.65.88.05.67.48.68.28.37.811.713.28.06.44.56.45.86.55.04.95.63.86.98.56.47.87.74.68.61.923.410.76.44.18.412.512.114.211.213.412.414.214.018.024.019.210.616.914.818.710.311.916.819.916.316.9
Operating margin10.9%11.0%9.1%18.2%19.3%17.4%9.3%9.8%9.1%4.7%3.3%10.1%9.4%7.2%8.2%8.1%8.4%12.1%5.0%11.8%7.8%5.8%6.2%10.4%11.9%8.4%9.7%11.4%11.5%12.5%11.1%13.5%14.4%10.2%9.1%9.1%12.8%11.0%11.9%9.1%8.8%8.8%5.7%8.6%9.7%9.1%9.4%9.1%6.2%11.3%2.6%18.8%9.6%6.5%4.2%7.1%11.5%9.2%11.0%9.6%11.7%9.0%9.0%8.7%12.0%13.9%11.7%7.7%10.2%9.3%9.4%5.5%6.4%8.5%9.8%8.4%9.1%
Other income0.51.10.50.2-2.8-0.6-0.40.93.81.42.50.11.70.70.90.9-0.2-2.62.2-2.01.5-0.41.0-0.9-1.41.11.81.2-0.60.70.90.5-1.00.31.21.41.00.51.12.42.71.61.51.11.51.20.81.30.81.01.13.13.42.51.61.91.90.31.01.02.02.11.03.52.13.72.83.73.40.91.43.41.04.1-1.23.10.6
Interest0.10.10.10.10.20.40.20.00.00.00.00.00.00.10.00.00.00.00.30.00.00.00.00.00.00.00.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.10.10.10.10.10.60.50.50.40.10.20.40.60.20.10.10.00.00.00.10.10.10.10.20.30.00.20.10.10.10.00.1
Depreciation0.30.30.30.30.30.30.30.30.30.30.20.20.30.30.30.30.30.30.40.40.40.40.50.40.50.50.40.50.50.51.90.50.60.60.60.50.40.50.50.40.50.40.50.30.40.40.50.91.01.04.13.73.73.83.83.03.03.03.02.42.42.42.42.02.12.22.21.91.92.22.82.52.93.03.02.42.5
Profit before tax3.23.73.05.73.63.31.64.36.73.23.73.76.23.73.84.74.45.03.95.45.23.04.14.56.16.28.79.47.18.56.811.711.67.77.05.37.05.87.17.07.16.74.87.79.67.18.08.04.38.4-1.622.39.94.71.77.111.08.912.19.712.912.112.815.417.925.319.712.318.213.317.310.99.917.815.516.915.1
Tax1.21.20.92.01.10.80.61.41.60.81.31.11.91.11.11.41.31.60.91.71.60.81.11.11.91.93.02.82.42.81.93.64.22.51.81.42.11.52.51.42.21.81.62.02.61.72.72.11.32.1-0.75.63.20.50.81.52.41.53.12.33.02.83.23.74.06.24.42.83.12.94.82.62.34.43.85.53.8
Net profit2.02.52.23.72.52.61.02.85.12.52.42.54.32.62.83.33.13.52.93.73.62.23.03.54.14.35.76.64.85.75.08.07.45.25.13.94.94.24.65.65.04.93.25.77.05.45.35.93.06.3-0.916.76.64.20.95.68.67.58.97.39.99.39.611.813.819.115.49.515.010.312.58.37.613.411.711.411.2
EPS ₹7.348.977.7913.379.089.303.5410.2118.378.868.599.1115.333.083.313.953.744.183.504.424.342.633.624.134.965.166.817.865.696.815.979.612.972.082.051.551.941.701.822.521.981.971.302.272.782.152.122.341.202.53-0.376.671.320.830.181.121.721.491.781.461.981.861.922.352.763.813.061.903.002.062.491.660.761.341.171.141.12
Revenue YoY————26.2%-2.5%-18.1%16.2%1.8%75.9%68.5%0.6%41.9%0.6%-10.4%33.8%16.4%42.2%20.7%29.4%-12.1%-0.2%21.7%-15.6%28.7%1.9%30.0%35.6%5.5%-0.7%-7.4%15.2%28.6%18.3%-1.1%-43.4%-45.1%-33.5%-22.0%11.6%10.2%21.5%22.7%46.4%58.0%10.5%23.8%5.8%-15.1%8.4%-13.2%46.4%51.3%29.6%34.8%-5.6%-3.1%33.9%32.8%-0.8%5.8%5.4%22.0%38.8%29.9%24.1%4.2%-14.6%11.0%-7.3%20.9%35.2%12.0%23.6%2.0%3.9%-0.3%
Profit YoY————24.0%3.6%-54.8%-23.7%102.0%-4.6%143.9%-10.6%-16.4%4.0%15.5%29.9%-26.7%36.2%5.8%11.8%15.7%-37.1%3.4%-6.5%14.4%95.9%88.4%90.1%14.7%32.0%-12.5%22.3%56.4%-8.4%3.2%-51.5%-34.5%-18.4%-11.1%44.0%1.8%16.0%-28.9%1.8%40.3%9.5%63.4%3.0%-56.8%17.4%-117.3%184.8%120.6%-34.1%—-66.6%29.5%78.2%892.2%31.1%15.3%25.0%7.7%60.3%39.4%105.3%59.7%-19.1%8.7%-45.9%-18.9%-12.7%-49.4%30.1%-6.3%37.6%47.3%

Returns & margins

trailing-twelve-month, per quarter
showing latest 8 of 74 periods
JUN '08SEP '08DEC '08MAR '09JUN '09SEP '09DEC '09MAR '10JUN '10SEP '10DEC '10MAR '11JUN '11SEP '11DEC '11MAR '12JUN '12SEP '12DEC '12MAR '13JUN '13SEP '13DEC '13MAR '14JUN '14SEP '14DEC '14MAR '15JUN '15SEP '15DEC '15MAR '16JUN '16SEP '16DEC '16MAR '17JUN '17SEP '17DEC '17MAR '18JUN '18SEP '18DEC '18MAR '19JUN '19SEP '19DEC '19MAR '20JUN '20SEP '20DEC '20MAR '21JUN '21SEP '21DEC '21MAR '22JUN '22SEP '22DEC '22MAR '23JUN '23SEP '23DEC '23MAR '24JUN '24SEP '24DEC '24MAR '25JUN '25SEP '25DEC '25MAR '26JUN '26SEP '26
ROE———————————————————————————————————————————————————————————————————14.5%14.2%11.8%12.8%11.7%12.5%13.3%
ROCE———————————————————————————————————————————————————————————————————18.3%17.9%15.9%17.2%15.5%17.2%17.3%
Net margin8.7%8.6%8.7%8.1%7.1%9.1%7.8%7.8%7.6%6.5%6.5%6.9%6.8%6.0%5.9%5.7%5.5%5.9%5.4%5.2%5.3%5.2%6.0%6.6%7.2%7.4%7.8%7.7%7.9%8.3%7.8%7.9%7.5%7.7%8.2%8.5%9.1%8.9%8.8%7.8%7.1%7.0%7.0%7.3%7.2%6.3%6.5%4.7%7.3%7.5%6.5%6.6%4.1%4.6%5.0%6.3%6.7%6.8%7.1%6.9%7.1%7.3%8.5%9.3%9.3%9.2%8.0%7.2%6.5%5.3%5.4%5.3%5.7%6.1%
EBITDA margin12.4%14.7%16.0%16.4%14.0%11.1%7.9%6.5%6.5%6.8%7.5%8.7%8.2%8.0%9.4%8.7%9.6%9.6%7.8%7.9%7.4%8.6%9.2%10.0%10.3%10.3%11.2%11.6%12.2%13.0%12.4%12.0%11.1%10.2%10.4%11.2%11.2%10.2%9.6%8.0%8.0%8.3%8.4%9.2%9.3%8.5%9.0%7.4%11.1%11.6%10.4%10.3%7.0%7.4%8.1%9.7%10.3%10.4%10.3%9.7%9.4%9.7%11.0%11.6%11.5%11.0%9.8%9.2%8.5%7.6%7.5%7.6%8.3%9.0%
Debt / equity———————————————————————————————————————————————————————————————————0.030.030.000.000.000.000.05
Interest coverage58.8542.0323.4017.9317.1926.6359.52150.25193.33240.86133.69145.92116.00112.13201.0047.2653.0355.0849.42443.00561.00443.75418.60255.80276.73349.67422.50638.00855.00966.25946.50949.50790.25540.00625.50628.75671.75901.00932.33642.25527.40411.57195.40180.94131.7295.7691.0624.9529.6225.5419.5626.7019.9922.4923.0830.4135.4347.80123.89216.77296.67364.75265.56224.74160.94140.8094.31101.0288.7886.70140.95113.96223.96273.21
Asset turnover———————————————————————————————————————————————————————————————————1.311.401.441.511.381.401.41

Balance sheet

equity vs borrowings over time · ₹ crore
MAR '25SEP '25MAR '26SEP '26
Share capital25.150.150.150.1
Other equity / reserves301.0276.8302.1309.8
Total equity326.0326.9352.2359.9
Borrowings10.50.00.019.5
Current liabilities178.5179.8203.0191.9
Non-current liabilities2.12.02.11.9
Total assets506.6508.7557.4553.7
Property, plant & equipment49.652.848.044.7
Capital work-in-progress0.30.50.00.2
Investments105.870.784.4112.8
Inventories74.5118.2147.8172.4
Receivables215.9235.1238.6189.8
Cash & equivalents19.61.98.19.4

Cash flow

annual · ₹ crore · line = free cash flow
FY25FY26
Cash from operations37.1-3.0
Cash from investing-19.917.8
Cash from financing-4.9-26.3
Capex20.07.9
Free cash flow17.2-10.9
Dividends paid12.515.0

Where the assets sit

Sep '26 · ₹ crore
Fixed assets (PPE)
₹44.7 cr8%
CWIP
₹0.2 cr0%
Investments
₹112.8 cr20%
Inventories
₹172.4 cr31%
Receivables
₹189.8 cr34%
Cash & equivalents
₹9.4 cr2%
Other assets
₹24.2 cr4%

Peer comparison

largest in Unclassified · this company in bold
CompanyMarket cap ₹crPriceP/EP/BROE
Avantel Limited36,86,04,549138.69—1059360.680.0%
Ducol Organics And Colours Limited19,55,275120.00—20089.130.0%
Jio Platforms Limited12,57,1811,406.40—3.57—
SBI Funds Management Limited1,01,750499.55———
Tamilnadu Telecommunication Limited91,3149.93———
Manipal Health Enterprises Limited76,294646.70———
INDO-MIM Limited59,0421,219.50———
AvenuesAI Limited45,138129.25153.69.516.2%
Dhoot Transmission Limited32,7611,601.60—8.11—
3M India Limited31,07127,570.0053.817.5732.7%
Anuh Pharma Limited81781.5517.12.2713.3%

StoxGud checklist: Neutral setup · 5/10

  • Price above 50-day average
  • Price above 200-day average
  • 50-day average above 200-day (uptrend)
  • RSI in healthy 40–70 zone
  • Positive 1-year return
  • Return on equity above 15%
  • Debt to equity below 1
  • Revenue growing year on year
  • Net profit margin above 10%
  • P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-4.6%
6 months-1.7%
1 year-9.0%
3Y CAGR—
5Y CAGR—
10Y CAGR—
50-day avg₹85.38
200-day avg₹79.79
RSI (14)48

FAQs

What is the share price of Anuh Pharma Limited?

Anuh Pharma Limited (ANUHPHR) closed at ₹81.55 on NSE on 06 Nov 2026.

What is the market cap of Anuh Pharma Limited?

₹817 crore at the latest close.

What is the P/E ratio of Anuh Pharma Limited?

17.1, on trailing-twelve-month earnings from its filings.

How fast is Anuh Pharma Limited growing?

Anuh Pharma Limited: revenue has compounded at 13.5% a year over three years; net profit at 4.3% a year. Latest-quarter revenue is down 0.3% year on year, profit up 47.3%.

How profitable is Anuh Pharma Limited?

On a trailing-twelve-month basis return on equity is 13.3%, return on capital employed 17.3%, operating margin 9.0%, net margin 6.1%.

How much debt does Anuh Pharma Limited have?

Anuh Pharma Limited is lightly geared: debt to equity is 0.05 with borrowings of ₹19 cr against cash of ₹9 cr (balance sheet of 2026-09-30). Operating profit covers interest 273.2 times.

Financials parsed from Anuh Pharma Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from SEP '07, annual from FY09, balance sheet from Mar '25. * = derived (full year or half year minus earlier quarters). † = the company's standalone results as published on BSE, used for quarters before DEC '24 (full years marked † are summed from them); cross-checked against the NSE filings where both exist. Information only, not investment advice.